Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI)

BACKGROUND: Community acquired pneumonia (CAP) is a major cause of morbidity, hospitalization, and mortality worldwide. Management of CAP for many patients requires rapid initiation of empirical antibiotic treatment, based on the spectrum of activity of available antimicrobial agents and evidence on...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuzman, Ilija, Bezlepko, Alexandr, Kondova Topuzovska, Irena, Rókusz, László, Iudina, Liudmyla, Marschall, Hans-Peter, Petri, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105837/
https://www.ncbi.nlm.nih.gov/pubmed/24975809
http://dx.doi.org/10.1186/1471-2466-14-105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105837/
https://www.ncbi.nlm.nih.gov/pubmed/24975809
http://dx.doi.org/10.1186/1471-2466-14-105

Ejemplares similares